U
pper extremity masses are commonly encountered by a variety of health care practitioners. Hand surgeons frequently evaluate such masses. From benign mucinous cysts about the wrist to aggressive bony malignancies with significant metastatic potential, the range of diagnoses is extremely wide. [1] [2] [3] Therefore, the associated prognoses for upper extremity masses can range from excellent to life threatening. Early correct diagnosis-and thus early intervention-can greatly affect patient outcome, particularly regarding sarcomas and other upper extremity malignancies.
1,2,4-6 When evaluating upper extremity masses, orthopedic surgeons must have a high index of suspicion for rare diagnoses and must know when to refer cases to an orthopedic oncologist. 7 This article offers guidance regarding the initial workup of upper extremity masses to evaluate whether they are benign or malignant. The authors provide an overview of the wide range of diagnoses for upper extremity masses. They also provide an algorithm to assist with determining when upper extremity masses require prompt or further investigation vs referral to an orthopedic oncologist (Figure 1 ).
Benign and Malignant lesions
Lesions of the upper extremities can generally be classified as either benign or malignant and further subclassified based on either bone or soft tissue etiology. Most are benign and in the treatment domain of a general medical or surgical practice. [1] [2] [3] Common benign and malignant masses are listed in Table 1 and Table 2 , respectively. 1, [8] [9] [10] [11] [12] [13] [14] Soft tissue and bony malignancies are far less common; however, given their potential for devastating morbidity and death, they must be properly identified early in the disease process.
To promptly differentiate a malignant lesion from a benign lesion, a comprehensive history of symptoms must be obtained and a physical examination must be performed. Both should be conducted in the context of the patient's pertinent medical comorbidities and risk factors for malignancy, as these factors can influence the orthopedic surgeon's index of suspicion for malignancy.
Orthopedic surgeons must be familiar with the typical history, physical examination findings, and presentation of patients who have bony or soft tissue lesions. Patients with a bony lesion typically present to discuss the presence of a lesion found
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The appropriate evaluation of hand and upper extremity masses is an important aspect of the care of orthopedic patients. Although most of these masses are benign, the orthopedic surgeon must have a high index of suspicion when assessing them because early diagnosis and treatment of aggressive or malignant masses may have a great effect on patient outcomes. This article provides an overview of benign and malignant osseous and soft tissue masses that orthopedic surgeons may encounter and a detailed algorithm for evaluating these masses. [Orthopedics. 201x; xx(x):xx-xx.] incidentally on prior imaging or for further evaluation of pain in a specific area of the upper extremity. 7 Patients may also report constitutional symptoms or specific neurological deficits. Pain is typically the presenting symptom in patients with aggressive bony lesions. Pain is the presenting symptom in 85% of patients with osteosarcoma. 1 The quality, duration, timing, and severity of pain must be carefully elucidated. Classic descriptions of bony pain include the presence of night pain, a deep and dull aching pain, and pain with weight bearing, although the subjective nature of pain can make these descriptions less clear. 1, 7, 14 On the initial evaluation of a soft tissue mass, the chief presenting complaint is typically the presence of a painless, enlarging lesion found incidentally by the patient; pain in a specific region of the upper extremity is rare. 7 The history should include information regarding the size and location of the mass, the presence or absence of pain, and, most importantly, the duration of the mass and changes to it over time. A small mass that has been present for years with no appreciable change in size does not rule out malignancy. Similarly, many soft tissue masses-including malignancies-are painless. A mass that fluctuates in size is typically more indicative of a benign process such as a hemangioma or a ganglion cyst. Pain not associated with a specific traumatic event, of relatively recent onset, not related to activity, or progressive in nature is suggestive of a more malignant process. 4 Additionally, fever, chills, malaise, or unexpected weight changes may indicate a more aggressive process such as an infection or advanced sarcoma. 1, [7] [8] [9] [12] [13] [14] Although a cornerstone of the initial workup of an upper extremity lesion, the physical examination yields no definite findings that consistently distinguish benign from malignant processes. The physical examination should be comprehensive and include evaluation of all of the major physiological systems. Regional lymphadenopathy, neurovascular changes due to compression, palpable masses or fullness, and skin changes should be further investigated. 1, 7, 14 Orthopedic surgeons should also consider auscultation of lung fields to check for pulmonary symptoms that could suggest the presence of an obstructive mass. Suspicion of infection, including osteomyelitis, should prompt laboratory studies: complete blood count, erythrocyte sedimentation rate, C-reactive protein, and blood cultures. A comprehensive history and physical examination reduce the possibility of overlooking or missing the diagnosis of a malignancy and provide a wealth of information in differentiating malignant from benign masses.
Further Workup oF lesions

Imaging
When a bony or a soft tissue lesion is suspected based on the history, presenta- tion, and physical examination, radiographic imaging of the relevant area is the next step. Radiographs are rapid and inexpensive. They may provide further information about the lesion and its extent in the surrounding anatomical environment. Initial studies should include orthogonal radiographs of the entire bone or soft tissue of interest as well as the joint above and below the anatomical site. For example, a chief complaint of arm pain should be investigated by obtaining radiographs of the humerus, shoulder, and elbow. It is crucial to obtain representative anatomical radiographs at the initial evaluation because the progression of some bony lesions can be evaluated and monitored through serial radiographs over time. Malrotation or suboptimal positioning for radiographs can result in projectional differences radiographically of the involved extremity, which can complicate interpretation when comparing serial radiographs.
Several unique radiographic features, including location, character, periosteal reaction, and zone of transition, help to differentiate a benign process from a malignant process. 1 In addition, soft tissues surrounding a lesion can be partially evaluated with radiographs. This can provide valuable information as to whether a bony lesion has osseous containment or if there is adjacent soft tissue extension, which may suggest a more aggressive or malignant process. Bony destruction, a wide zone of transition, extraosseous calcification, and periosteal reaction suggest a more pathological process ( Table 3) . Radiographic imaging of upper extremity soft tissue masses can also provide valuable information regarding extent in the soft tissue and the bone, and can be used to assess for bony involvement or soft tissue calcifications.
Advanced imaging modalities such as computed tomography, gadolinium contrast-enhanced magnetic resonance imaging, or transillumination studies are frequently used for bone and soft tissue masses. Magnetic resonance imaging can be particularly useful for assessing soft tissue masses and extension of bony masses into soft tissues (Figure 2) . Computed tomography is more useful when greater bony detail is desired, or when patients are unable to undergo magnetic resonance imaging because of retained metal fragments or implants. Transillumination of a suspected lesion is a rapid and inexpensive way to gain additional information. Many common lesions such as ganglion cysts transilluminate once a light source is applied to them, which suggests that they have a significant water component. 15 These advanced imaging techniques further characterize masses and can be repeated over time to determine if masses are dynamic and changing.
Biopsy
Data obtained from the history, physical examination, and imaging are amalgamated to generate a differential diagnosis. If the findings of the workup suggest a low probability of a malignant process, it is reasonable to closely observe the mass. However, if suspicion exists that a mass is malignant, a biopsy is required to reach the correct diagnosis. 2, 5, 12, 13, 16, 17 A biopsy can have an important effect on subsequent care and eventual outcome. To optimize patient outcome, it is typically best to have an open biopsy performed by an oncologically trained orthopedic surgeon or by an interventionalist famil- There are many technical and planning factors to consider when performing a biopsy. Orthopedic surgeons must adhere to the generally accepted principles of tissue biopsy. Before the biopsy is performed, all imaging should be reviewed to determine the boundaries of the lesion. 18 The correct site should be biopsied, and both normal and abnormal tissue should be obtained for the pathologist to compare. If the mass is especially large, multiple biopsy specimens can be taken from different areas of the mass to ensure that "representative" tissue is obtained. The optimal biopsy approach should be used to reduce potential contamination by malignant cells.
The biopsy should be oriented along the long axis of the extremity so that the biopsy tract can be excised at a later date, in the event of a surgical procedure. This is especially the case for hand surgery, as suboptimal biopsy incisions may result in digit sacrifice if the biopsy specimen is malignant. Any excised tissue and remaining tissue bed in vivo should be appropriately tagged and oriented using sutures, staples, or equivalent fixation because this will help both the surgeon and the pathologist in orienting the sample. The excised tissue should be prepared according to the standards of the pathology laboratory to which the sample will be submitted. The surgeon must ensure that the pathologist and the laboratory are available and have the resources to support the biopsy effort. Finally, once the biopsy has been completed, meticulous attention must be paid to hemostasis to minimize the spread of blood from the biopsied compartment to surrounding compartments.
Surgical intervention, including biopsy or resection of the mass, should ideally be performed by a surgeon familiar with both benign and malignant conditions. Consultation with a fellowship-trained orthopedic sarcoma surgeon, or a dermatologic surgeon in the case of suspected skin cancer, should occur promptly if there is a heightened suspicion of malignancy. An inappropriate biopsy can have catastrophic consequences. A poorly planned biopsy of a malignant mass can potentially result in seeding of the surrounding soft tissues with tumor and lead to large surgical resections. As a general rule, an upper extremity mass should be biopsied only if the capability and infrastructure exist to support removal of the mass without adversely affecting patient outcome. Strict adherence to the aforementioned principles of lesion biopsy will help orthopedic surgeons minimize morbidity and maximize the odds of successful outcomes.
Bone lesions
Benign
Most bony lesions of the upper extremity are benign. They include enchondromas, osteochondromas, aneurysmal bone cysts, and simple bone cysts. Many of these lesions are found incidentally when patients present for other injuries to the upper extremity and are well within the scope of practice for hand surgeons. Most of these benign lesions are also asymptomatic. Enchondromas remain one of the most common primary bone tumors of the hand. These cartilaginous lesions are usually observed; however, if they are locally destructive, curettage and bone grafting may be necessary. 19 Although most enchondromas are benign, there is a small chance of their transformation to malignant chondrosarcoma, or they can be found as a malignant entity in the con- text of either Maffucci syndrome or Ollier disease. 19 Osteochondromas are common benign bony lesions that arise from cartilage precursors and can be found in the hand and upper extremity. These masses are found incidentally and are typically painless and firm. Radiographically, osteochondromas are broad or narrow lesions in continuity with the bone that grow away from the joint. Surgical excision is curative.
Cystic masses such as aneurysmal bone cysts and simple bone cysts, which are usually found in younger patients (ie, during the first or second decade of life), are typically benign bony lesions. 20 Patients with aneurysmal bone cysts typically present with swelling and pain in the affected extremity. Aneurysmal bone cysts are known for their propensity to accumulate blood in cystic cavities, which is readily apparent in "fluid-fluid" levels on magnetic resonance imaging. These lesions can be locally aggressive, and it is not uncommon for pathological fracture to occur through them. 20 Aneurysmal bone cysts can typically be treated with intralesional curettage and bone graft with autograft or allograft struts if they are large. The malignant lesion telangiectatic osteosarcoma can sometimes be confused with the aneurysmal bone cyst. Therefore, some orthopedic surgeons refer all suspected aneurysmal bone cysts to orthopedic oncologists for management. In contrast to patients with aneurysmal bone cysts, patients with simple bone cysts typically do not have pain and swelling; they instead present with a pathological fracture through the lesion. A common presentation is that of a child or an adolescent playing overhand sports and suffering a pathological fracture through a simple bone cyst located in the proximal humerus, a common site of these lesions. Many of these upper extremity lesions can be treated nonoperatively with simple immobilization; however, they may require bone grafting if they do not heal.
Malignant
Malignant bone masses of the hand and upper extremity are rarer than benign bone lesions. However, maintaining an appropriately high index of clinical suspicion based on the presenting history, symptoms, and imaging findings ensures that the rare malignant bone lesions are not overlooked or misdiagnosed. Bony lesions in the upper extremity comprise 2 groups: primary lesions and metastatic disease. The classic age distribution of patients with a primary bony malignancy is bimodal: the second and third decades of life and the sixth and seventh decades of life. Bony metastatic disease is a more common source of bony lesions and typically involves the spread of malignant disease from the lungs, prostate, breast, or colon. Although a detailed review of all of the malignant lesions of the hand and upper extremity is beyond the scope of this article, it is appropriate to comment on some of those that orthopedic surgeons or hand surgeons may encounter. These include metastatic bony lesions, osteosarcoma, Ewing's sarcoma, and chondrosarcoma.
Compared with other anatomical areas, the hand is a less common location for metastatic tumors, with it being estimated that 0.1% of osseous metastatic tumors 
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spread to the hand. 21 However, given the serious nature of a malignant lesion of the hand and the local aggressiveness of many such lesions, a timely diagnosis is essential. When a lesion is encountered and thought to represent metastatic disease, an appropriate search for the primary lesion may include magnetic resonance imaging of the extremity, computed tomography of the chest, abdomen, and pelvis, serological workup, and bone scans (Figure 3) . The search for the primary tumor is critical because patients who have a diagnosed metastatic lesion of the hand have a poor prognosis, with an estimated mean survival time of approximately 6 months. 22 Primary malignant tumors of the hand are rarer than metastatic disease. They include osteosarcoma, Ewing's sarcoma, and chondrosarcoma. Osteosarcoma typically occurs in the long bones of patients who are 15 to 25 years old, but can be found in the hand and upper extremity. 23 Osteosarcoma neoplasms have a radiographic "sunburst" appearance due to their periosteal reaction. Ewing's sarcoma, which is strongly associated with the t(11:22) chromosomal translocation, is commonly found in the pediatric population. This bony neoplasm has typical aggressive radiographic features consisting of an expansile lesion with cortical erosions and a permeative appearance. 24 Both osteosarcoma and Ewing's sarcoma are typically managed with a combination of chemotherapy and surgery. A malignant bone tumor more commonly found in adults is chondrosarcoma, which can evolve from a benign enchondroma. 25 This challenging lesion is typically resistant to radiation and chemotherapy. It is usually managed by surgical resection only. When an orthopedic surgeon or a hand surgeon encounters lesions in which malignant behavior is suspected, prompt referral to an orthopedic oncologist is crucial to optimize patient outcome and treatment.
soFt tissue lesions
Benign
The most common tumors of the upper extremity are ganglion cysts, comprising 60% to 70% of all hand tumors, and giant cell tumors of the tendon sheath ( Table  1) . Ganglion cysts most commonly arise from the dorsal aspect of the scapholunate ligament, and are found on the dorsum of the wrist. Ganglion cysts can also arise on the volar aspect of the wrist, and may originate from the synovial joints of the wrist and hand. Wrist ganglion cysts can be assessed by ultrasound, although radiographs can be used to evaluate for scapholunate ligament injuries associated with them. 7 Related entities include peritendinous retinacular cysts and osteoarthritic mucinous cysts. These masses are typically diagnosed on the basis of history and physical examination, with advanced imaging seldom being needed. Treatment can range from observation to surgical excision, depending on the presence or absence of symptoms and the time course. 17 Giant cell tumors of the tendon sheath most often occur as slowly growing lobulated lesions of the hand and should not be confused with giant cell tumors of the bone. Prognosis and treatment vary considerably between the 2 diagnoses despite similar nomenclature. If symptomatic, a giant cell tumor of the tendon sheath can be surgically excised, with reported recurrence rates ranging from 10% to 50%.
17
Malignant
Malignant soft tissue lesions of the upper extremity can be categorized as skin cancers and soft tissue sarcomas. Only 1% to 2% of tumors arising in the hand are malignant. 6 Of those, skin cancer encompasses the majority, including squamous cell carcinoma, basal cell carcinoma, and melanoma (Figure 4) . Soft tissue sarcomas are rare in general and even more so in the hand. Approximately 5000 new cases are diagnosed annually in the United States, with only 15% of these occurring in the upper extremity. Of these, most are located proximal to the hand and wrist, with 2% occurring in the hand. 5 Soft tissue sarcomas occurring more commonly 
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in the hand and upper extremity include epithelioid sarcoma, synovial sarcoma, clear cell sarcoma, and malignant fibrous histiocytoma. 5 Prompt referral to a hand or sarcoma specialist is essential in these cases. They have a propensity to metastasize, and often require a tissue biopsy and histopathological analysis for tumor identification. Treatment varies by location but typically involves a wide local resection vs amputation.
5
ConClusion
Upper extremity bony and soft tissue masses are commonly encountered by orthopedic surgeons. Appropriate recognition of both benign and malignant lesions is critical. Although the range of diagnoses is wide, the guidelines presented here may assist orthopedic surgeons in the appropriate workup of upper extremity masses. When orthopedic surgeons have an elevated clinical suspicion of either a malignancy or an aggressive soft tissue or osseous process, they should promptly refer to an orthopedic oncologist and tertiary care center.
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